Prognosis in stage II colon cancer: Expanding the horizons of risk factors

doi:10.4251/wjgo.v17.i2.100552

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (125)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=62

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=43

Publishing Process of This Article

Item

Count

Browse

Download

Sum=15

Feb 15, 2025 (publication date) through Jan 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100552
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100552

Open in New Tab Full Size Figure Download Figure

Figure 1 Additional recommended risk factor analyses for the prognostic evaluation of stage II colon cancer patients. These include factors associated with the tumor and its microenvironment, immune and inflammatory status, diet, and nutritional balance. These key parameters, in combination with the study of traditional risk factors, will improve treatment selection and possibly prevent relapse in these patients. CA19-9: Carbohydrate antigen 19-9; CD44: Cluster of differentiation 44; CEA: Carcinoembryonic antigen; TME: Tumor microenvironment; TNM: Tumor-node-metastasis.

Citation: Novoa Díaz MB, Gentili C, Martín MJ, Carriere P. Prognosis in stage II colon cancer: Expanding the horizons of risk factors. World J Gastrointest Oncol 2025; 17(2): 100552
URL: https://www.wjgnet.com/1948-5204/full/v17/i2/100552.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.100552